-
Lesinurad (brand name Zurampic) is a
urate transporter inhibitor for
treating high
blood uric acid
levels ****ociated with gout. It is
recommended only...
-
Lesinurad/allopurinol (trade name Duzallo) is a fixed-dose
combination drug for the
treatment of gout. It
contains 200 mg of
lesinurad and 300 mg of allopurinol...
- M04AB02
Sulfinpyrazone M04AB03
Benzbromarone M04AB04
Isobromindione M04AB05
Lesinurad M04AC01
Colchicine M04AC02
Cinchophen M04AC51
Colchicine and probenecid...
- Milurit, Alloril, Progout, Ürikoliz, Zyloprim, Zyloric, Zyrik, and Aluron.
Lesinurad/allopurinol, a fixed-dose
combination drug "Allopurinol Use
During Pregnancy"...
- rate of side
effects and many
people develop resistance to it.
Using lesinurad 400 mg plus
febuxostat is more
beneficial for
tophi resolution than lesinural...
- [citation needed]
Uricosuric agents (benzbromarone, benziodarone, probenecid,
lesinurad, sulfinpyrazone, ethebencid, zoxazolamine, and ticrynafen)
increase the...
- SLC22A12 has been
shown to have a protein-protein
interaction with PDZK1.
Lesinurad, Ruzinurad, Verinurad, Epaminurad, Lingdolinurad, Xininurad, Puliginurad...
-
particularly OCT2. It can
affect the
pharmacokinetics of
other cationic drugs.
Lesinurad: This drug
inhibits URAT1 (Urate
Transporter 1) in the
proximal tubule...
-
Biosciences for $1
billion (Net of
existing cash)
including lead
product lesinurad in
Phase III
development for gout". AstraZeneca. 23
April 2012. Retrieved...
